Russia claims it's on track to approve Covid-19 vaccine by mid-August. But speed of process raises questions
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
Costa Rica is set to begin clinical trials on antibody-rich plasma that has been extracted from horses with the purpose of treating COVID-19 patients.
Two versions of the plasma were shown to inhibit the infectivity of SARS-CoV-2, the virus that causes COVID-19, in tests performed at the National Center for Biodefense and Infectious Diseases in the United States.
Submitted by mike kraft on
ARIS (AP) — As the sun went down, their partying got into full flow, with an unwanted guest: the coronavirus.
An outbreak among 18- to 25-year-olds at a seaside resort on the Brittany coast is crystallizing fears that the virus is flaring again in France, on the back of vacationers throwing COVID-19 caution to the summer winds.
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
At least 667,650 people globally have died from COVID-19 and 17,118,787 have been infected by the novel coronavirus that causes it, following an outbreak that started in Wuhan, China, in early December. The World Health Organization referred to it as a pandemic on March 11, 2020.
Submitted by mike kraft on
Submitted by mike kraft on
In a laboratory in New York City, researchers coaxed a key piece of the coronavirus — its infamous outer “spike” — to mutate so that it became invisible to disease-fighting antibodies, according to a new study that has not yet been published in a scientific journal.
Submitted by mike kraft on
Amid the chaos of the pandemic’s early days, doctors who faced the first coronavirus onslaught reached across oceans and language barriers in an unprecedented effort to advise colleagues trying to save lives in the dark.
Submitted by mike kraft on